Compared to recovered patients, IFN-γ remained elevated at 2 months, tumor necrosis factor-α (TNF-α) at 4 months and IFN-β and IFN-λ1 at 11 months in LC patients [96,220]. The gene discussed is IFNL1; the disease is laryngotracheoesophageal cleft.